Literature DB >> 16369973

Ikaros increases normal apoptosis in adult erythroid cells.

Dianne Pulte1, Rocio A Lopez, Shane T Baker, Maureen Ward, Ellen Ritchie, Christine A Richardson, David W O'Neill, Arthur Bank.   

Abstract

Ikaros is a critical transcriptional regulator of hematopoietic cell differentiation. In addition to its effects on the lymphoid system and hematopoietic stem-cell compartment, we have previously shown that Ikaros is also required for normal erythroid development. In this report, we compare Ikaros-dependent gene expression in erythroid cells of mice lacking the Ikaros protein with that of normal mice in purified adult bone-marrow erythroid cells (BMRC). Gene expression, measured by Affymetrix microarray analysis, indicates that in the BMRC of Ikaros-null mice, there is significant up-regulation of SMADs 6 and 7, serine protease inhibitor 3, and immediate-early protein 3 (IER3), all proteins that play a modulating role in apoptosis. We investigate the role of Ikaros in oxidative stress-induced apoptosis using Annexin-V staining and FACS analysis. We find a decrease in apoptosis in the BMRC of Ikaros-null mice compared to normal mice. This effect is also seen in nonerythroid cells but is stronger in BMRC. We conclude that normal Ikaros function increases normal apoptosis in erythroid cells. The data also suggest that Ikaros plays a role in apoptosis-mediated events in other normal hematopoietic cell lineages. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369973     DOI: 10.1002/ajh.20507

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis.

Authors:  Julie Ross; Lionel Mavoungou; Emery H Bresnick; Eric Milot
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

2.  Ikaros and GATA-1 combinatorial effect is required for silencing of human gamma-globin genes.

Authors:  Stefania Bottardi; Julie Ross; Vincent Bourgoin; Nasser Fotouhi-Ardakani; El Bachir Affar; Marie Trudel; Eric Milot
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

3.  Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene.

Authors:  Frederick D Goldman; Zafer Gurel; Duha Al-Zubeidi; Ari J Fried; Michael Icardi; Chunhua Song; Sinisa Dovat
Journal:  Pediatr Blood Cancer       Date:  2011-05-05       Impact factor: 3.167

4.  Ikaros expression sensitizes leukemic cells to the chemotherapeutic drug doxorubicin.

Authors:  Licai He; Shenmeng Gao; Zhenfeng Zhu; Shang Chen; Haihua Gu
Journal:  Oncol Lett       Date:  2016-06-07       Impact factor: 2.967

5.  Bayesian hierarchical clustering for microarray time series data with replicates and outlier measurements.

Authors:  Emma J Cooke; Richard S Savage; Paul D W Kirk; Robert Darkins; David L Wild
Journal:  BMC Bioinformatics       Date:  2011-10-13       Impact factor: 3.169

6.  Regulation of host gene expression by HIV-1 TAR microRNAs.

Authors:  Dominique L Ouellet; Jimmy Vigneault-Edwards; Kevin Létourneau; Lise-Andrée Gobeil; Isabelle Plante; John C Burnett; John J Rossi; Patrick Provost
Journal:  Retrovirology       Date:  2013-08-12       Impact factor: 4.602

7.  A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.

Authors:  Daria Capece; Francesca Zazzeroni; Maria Michela Mancarelli; Daniela Verzella; Mariafausta Fischietti; Ambra Di Tommaso; Rita Maccarone; Sara Plebani; Mauro Di Ianni; Alberto Gulino; Edoardo Alesse
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.